Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Items 21 to 30 of 46 total

Set Ascending Direction
per page

The last decade has seen remarkable innovation and development in the nucleotide sequencing field. Today, a number of powerful high-throughput sequencing technologies are available and are being used ...

Read More
Comments | Posted By Claire Nicholson

Fluorescence Microscopy 2015

24/06/2015 10:15

Fluorescence microscopy is one of today's most important laboratory techniques and supports highly valued applications in fundamental biological research, live cell imaging and 3D structure, functiona...

Read More
Comments | Posted By Claire Nicholson

What our reports provide

24/06/2015 09:44

By profiling end-users' current activities and future plans, our studies assist laboratory suppliers and developers to identify new market opportunities... 

Our reports present the findings of speciali...

Read More
Comments | Posted in Key benefits of our global end-user studies By Claire Nicholson

What our reports provide

24/06/2015 09:44

Findings from our markets studies assist suppliers in more than twenty areas of commercial development, enabling improved ROI, cost reductions and reduced risk...

Our reports present the findings of sp...

Read More
Comments | Posted in Key benefits of our global end-user studies By Claire Nicholson

What our reports provide

24/06/2015 09:44

Findings from our markets studies assist suppliers in more than twenty areas of commercial development, enabling improved ROI, cost reductions and reduced risk...

Our reports present the findings of sp...

Read More
Comments | Posted in Key benefits of our global end-user studies By Claire Nicholson

Researchers have developed a new device that could help determine the presence of tumor cells circulating in the bloodstream


Cancer cells are sometimes known to break off from a tumor and travel throug...

Read More
Comments | Posted in Articles By Claire Nicholson

After apparently abandoning its acquisition of London-based drugmaker AstraZeneca, biopharma conglomerate Pfizer announced a stock repurchase plan of $11 billion last week, in conjunction with a recen...

Read More
Comments | Posted By Claire Nicholson

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated announces that its partner, GlaxoSmithKline (GSK) plc, presented the results from the Phase 3 PETIT2 study evaluating the efficacy of el...

Read More
Comments | Posted By Claire Nicholson

Italy will pay for patients to use Roche Holding AG’s cancer drug Avastin to treat an eye condition for which it’s not approved as the country looks to rein in medical costs.

 

The decision today by the...

Read More
Comments | Posted By Claire Nicholson

Aduro BioTech, Inc., a clinical-stage biotechnology company, today announced the closing of a $55 million Series C financing. New investor Johnson & Johnson Development Corporation (JJDC) joined the M...

Read More
Comments | Posted By Claire Nicholson

Items 21 to 30 of 46 total

Set Ascending Direction
per page